Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling

  • Holly M. Nguyen ,

    Contributed equally to this work with: Holly M. Nguyen, Nazanin Ruppender

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  • Nazanin Ruppender ,

    Contributed equally to this work with: Holly M. Nguyen, Nazanin Ruppender

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  • Xiaotun Zhang,

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  • Lisha G. Brown,

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  • Ted S. Gross,

    Affiliation Department of Orthopedics, University of Washington, Seattle, Washngton, United States of America

  • Colm Morrissey,

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  • Roman Gulati,

    Affiliation Biostatistics and Biomathematics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  • Robert L. Vessella,

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

  • Frauke Schimmoller,

    Affiliation Exelixis Inc, South San Francisco, California, United States of America

  • Dana T. Aftab,

    Affiliation Exelixis Inc, South San Francisco, California, United States of America

  • Eva Corey

    ecorey@uw.edu

    Affiliation Department of Urology, University of Washington, Seattle, Washington, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.